Voyager Therapeutics (纳斯达克代码: VYGR) 报告季度每股亏损$(0.59)，不及分析师一致预期的$(0.38)，差距为55.26%。相比去年同期每股收益$1.25，这次下降了147.2%。公司季度销售额为$627.8万，也不及分析师一致预期的$1657.7万，差距为62.13%。相比去年同期的$9006.1万，下降了93.03%。

以上内容来自Benzinga Earnings专栏，原文如下：

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.38) by 55.26 percent. This is a 147.2 percent decrease over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $6.278 million which missed the analyst consensus estimate of $16.577 million by 62.13 percent. This is a 93.03 percent decrease over sales of $90.061 million the same period last year.